St. Jude Medical has announced that it received FDA 510(k) clearance for the St. Jude Medical Invisible Trial System, which is a mobile-enabled discreet spinal cord stimulation (SCS) trial system.
Medical Device Network on MSN
Abbott touts neuromodulation portfolio’s long-term benefits
Abbott’s five-year data highlighted neuromodulation therapies’ role in reducing healthcare and patient burdens associated ...
GlobalData on MSN
Boston Scientific touts long-term data of SCS therapy
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
KNOXVILLE, Tenn. — Around 2 years ago, Chris Patterson fell off a ladder while responding to a call with the Knoxville Fire Department. He said Sedgwick, the third-party workman's compensation company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results